Leading academic centers, research institutes, contract research organizations and pharmaceutical companies worldwide rely on MediBeacon technology. More >>
Measurement of GFR is widely accepted as the best indicator of kidney function. A clinically practical and accurate real-time point of care methodology holds promise. More >>
Fluorescent agent angiography has the potential to aid in diagnosis and monitoring of vasculature leakage seen in Diabetic Retinopathy, Macular Degeneration and Retinal Vasculitis. More >>
Intraoperative identification of ureter or ureteral injury is critical to prevent serious complications. Use of fluorescent agents could potentially aid in surgical visualization. More >>
Industry leaders including scientists and clinicians are behind fluorescence enabled technology that has the potential to impact global health. More >>
Let us know how we can continue the conversation. More >>
PRODUCT PIPELINE
There is a brighter future through fluorescent technology.
MediBeacon’s robust platform of investigational agents are designed to facilitate measurement of what was once difficult or not possible to measure*. The applications being explored in nephrology and gastroenterology have the potential to expedite the identification, monitoring and treatment of kidney disease and gastroenterological disorders.
Focus is on bringing transformational technology into medical practice. Fluorescent tracer agent-based monitoring systems are well positioned to provide an indication of GFR, quantification of GI permeability, enhanced visualization of the vasculature during ocular angiography, and identification of the ureters during abdominal surgeries. Delivering products which have the potential to have a positive impact on both the quality and cost of patient care is the goal.
Fluorescent tracer agents could potentially have multiple applications across different medical disciplines. By targeting molecules of different molecular weights and light emission wavelengths new fluorescent tracer agent-based transdermal GFR systems are possible.
“Photonics plays a key role in next-generation health care, both in enhancing the ability to observe and measure symptoms and the capability to treat patients earlier with less invasive, more cost-effective methods.”
– National Photonics Initiative,
lightourfuture.org
MediBeacon Product Pipeline
Follow the progress: Sign up today to receive notifications of milestones, news and updates on MediBeacon fluorescent technology.